awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44062334-47FEAC2E-7FEC-4437-A593-F8DACCC9874B
Q44062334-47FEAC2E-7FEC-4437-A593-F8DACCC9874B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44062334-47FEAC2E-7FEC-4437-A593-F8DACCC9874B
Response to sorafenib treatment in advanced metastatic thyroid cancer.
P2860
Q44062334-47FEAC2E-7FEC-4437-A593-F8DACCC9874B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44062334-47FEAC2E-7FEC-4437-A593-F8DACCC9874B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ff373c71e15d58e2f9cfd565a131ac1ea036228
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr